Plexus Corp. (PLXS) Analysts See $0.74 EPS; 3 Analysts Bullish Alimera Sciences, Inc. (ALIM)

Alimera Sciences, Inc. (NASDAQ:ALIM) Logo

Analysts expect Plexus Corp. (NASDAQ:PLXS) to report $0.74 EPS on April, 18.They anticipate $0.10 EPS change or 11.90% from last quarter’s $0.84 EPS. PLXS’s profit would be $24.93 million giving it 20.18 P/E if the $0.74 EPS is correct. After having $0.75 EPS previously, Plexus Corp.’s analysts see -1.33% EPS growth. The stock increased 2.10% or $1.23 during the last trading session, reaching $59.73. About 266,354 shares traded or 54.58% up from the average. Plexus Corp. (NASDAQ:PLXS) has risen 1.46% since March 31, 2017 and is uptrending. It has underperformed by 10.09% the S&P500.

Among 3 analysts covering Alimera Sciences (NASDAQ:ALIM), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Alimera Sciences had 14 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co on Tuesday, July 11 with “Buy”. H.C. Wainwright maintained the shares of ALIM in report on Monday, January 22 with “Buy” rating. As per Wednesday, August 12, the company rating was maintained by Cantor Fitzgerald. The stock of Alimera Sciences, Inc. (NASDAQ:ALIM) has “Buy” rating given on Tuesday, July 25 by Cowen & Co. The company was maintained on Tuesday, January 19 by Cantor Fitzgerald. As per Friday, October 27, the company rating was maintained by H.C. Wainwright. The company was maintained on Wednesday, August 30 by H.C. Wainwright. Cowen & Co downgraded Alimera Sciences, Inc. (NASDAQ:ALIM) on Friday, May 6 to “Market Perform” rating. The firm has “Buy” rating given on Thursday, August 3 by Cowen & Co. The firm has “Outperform” rating by Cowen & Co given on Friday, September 16. See Alimera Sciences, Inc. (NASDAQ:ALIM) latest ratings:

22/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
22/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
27/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain

Investors sentiment decreased to 0.65 in 2017 Q4. Its down 0.45, from 1.1 in 2017Q3. It dived, as 22 investors sold Plexus Corp. shares while 79 reduced holdings. 23 funds opened positions while 43 raised stakes. 31.73 million shares or 1.43% more from 31.28 million shares in 2017Q3 were reported. 25,600 were reported by Systematic Financial Mgmt Ltd Partnership. Prudential Fincl invested in 0% or 55,662 shares. Vaughan Nelson Invest Management Ltd Partnership owns 581,975 shares. Fisher Asset Mngmt Llc has 0.06% invested in Plexus Corp. (NASDAQ:PLXS) for 699,730 shares. Pub Employees Retirement Association Of Colorado reported 0% of its portfolio in Plexus Corp. (NASDAQ:PLXS). Morgan Stanley invested in 0% or 105,783 shares. Gemmer Asset Mngmt Ltd reported 122 shares. 1.19 million were accumulated by Franklin Resource. Bankshares Of Montreal Can holds 0% or 1,844 shares. California-based Parallax Volatility Advisers Limited Partnership has invested 0% in Plexus Corp. (NASDAQ:PLXS). Arizona State Retirement Systems has invested 0.03% in Plexus Corp. (NASDAQ:PLXS). Legal And General Group Pcl holds 83,242 shares. Associated Banc holds 9,700 shares. Pacad Invest reported 649 shares stake. Stone Ridge Asset Management Ltd Liability Com reported 12,765 shares or 0.05% of all its holdings.

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company has market cap of $2.01 billion. It offers product conceptualization solutions; and product design and value-engineering solutions, including program management, feasibility studies, specification development for product features and functionality, circuit design, field programmable gate array design, printed circuit board layout, embedded software design, mechanical design, test specifications development and product verification testing, and automated production solutions and complex automation design. It currently has negative earnings. The firm also provides commercialization solutions, such as prototyping, new product introduction, design for supply chain, test development, and transition management; manufacturing solutions; and fulfillment and logistics solutions.

Since January 22, 2018, it had 1 buying transaction, and 7 selling transactions for $1.13 million activity. The insider Jermain Patrick John sold $270,345. On Monday, February 26 the insider CORTINOVIS STEPHEN P sold $383,120. $600,500 worth of stock was bought by KELLY PETER on Monday, January 22. Another trade for 5,900 shares valued at $348,277 was sold by Darroch Ronnie. Another trade for 6,500 shares valued at $395,875 was made by Kelsey Todd P. on Tuesday, February 20. DRURY DAVID J had sold 2,500 shares worth $151,825.

Among 11 analysts covering Plexus (NASDAQ:PLXS), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Plexus had 28 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Monday, August 28 by JP Morgan. The rating was maintained by RBC Capital Markets on Thursday, August 31 with “Hold”. On Thursday, July 20 the stock rating was maintained by Stifel Nicolaus with “Hold”. Stifel Nicolaus maintained the shares of PLXS in report on Thursday, January 18 with “Hold” rating. Citigroup maintained Plexus Corp. (NASDAQ:PLXS) on Friday, October 27 with “Neutral” rating. On Monday, August 3 the stock rating was upgraded by Goldman Sachs to “Buy”. The rating was downgraded by Goldman Sachs to “Neutral” on Friday, October 23. On Tuesday, October 10 the stock rating was downgraded by J.P. Morgan to “Hold”. Needham maintained Plexus Corp. (NASDAQ:PLXS) rating on Friday, July 24. Needham has “Strong Buy” rating and $46 target. The firm has “Hold” rating by Deutsche Bank given on Monday, September 7.

The stock decreased 0.96% or $0.01 during the last trading session, reaching $1.03. About 105,608 shares traded. Alimera Sciences, Inc. (NASDAQ:ALIM) has declined 28.28% since March 31, 2017 and is downtrending. It has underperformed by 39.83% the S&P500.

Since January 16, 2018, it had 1 buying transaction, and 10 selling transactions for $290,803 activity. The insider Ashman Philip sold 25,500 shares worth $31,475. Shares for $14,181 were sold by Green Kenneth. Shares for $16,063 were sold by EISWIRTH RICHARD S JR on Thursday, January 18. Shares for $63,379 were sold by Myers C. Daniel. Shares for $22,800 were bought by ARMISTICE CAPITAL – LLC. 25,500 shares were sold by Holland David, worth $31,475 on Tuesday, January 16.

Alimera Sciences, Inc. (NASDAQ:ALIM) Institutional Positions Chart